Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,928 | -154,808 | -119,943 | -76,941 | -36,684 |
| Depreciation Amortization | -447 | 3,866 | 3,953 | 3,244 | 1,862 |
| Accounts payable and accrued liabilities | 2,217 | 253 | 2,321 | -1,847 | -1,437 |
| Other Working Capital | -11,978 | -37,623 | -24,130 | -23,078 | -13,346 |
| Other Operating Activity | 7,168 | 35,227 | 24,250 | 19,342 | 9,310 |
| Operating Cash Flow | $-43,968 | $-153,085 | $-113,549 | $-79,280 | $-40,295 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,009 | -2,836 | -2,463 | -1,217 | -482 |
| Purchase Of Investment | -61,835 | -445,972 | -298,736 | -144,827 | -80,118 |
| Sale Of Investment | 90,428 | 469,327 | 371,384 | 253,710 | 106,463 |
| Investing Cash Flow | $24,584 | $20,519 | $70,185 | $107,666 | $25,863 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -327 | -1,130 | -825 | -533 | -264 |
| Common Stock Issued | 1,486 | 154,129 | 151,871 | 1,082 | 449 |
| Financing Cash Flow | $1,159 | $152,999 | $151,046 | $549 | $185 |
| Beginning Cash Position | 74,524 | 54,092 | 54,092 | 54,092 | 54,092 |
| End Cash Position | 56,299 | 74,525 | 161,774 | 83,027 | 39,845 |
| Net Cash Flow | $-18,225 | $20,433 | $107,682 | $28,935 | $-14,247 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,968 | -153,085 | -113,549 | -79,280 | -40,295 |
| Capital Expenditure | -4,009 | -2,836 | -2,463 | -1,217 | -482 |
| Free Cash Flow | -47,977 | -155,921 | -116,012 | -80,497 | -40,777 |